Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (13)
Oncogene (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (15)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Cell biology
Chemical biology
Diseases
Drug discovery
Health care
Immunology
Medical research

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–15 of 15 results

Advanced filters: Author: P Chevreau Clear advanced filters

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

In a trial of patients with soft-tissue sarcomas, clinical outcome measures following anti-PD-1 treatment were better in a cohort prospectively selected for the presence of intratumoral tertiary lymphoid structures than in other cohorts where most patients lacked these structures.

A. Italiano
A. Bessede
W. H. Fridman
Research26 May 2022
Nature Medicine

Volume: 28, P: 1199-1206
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

I Ray-Coquard
H Ghesquière
J-Y Blay
ResearchOpen Access11 Sept 2001
British Journal of Cancer

Volume: 85, P: 816-822
Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

C M L van Herpen
R L H Jansen
P H M De Mulder
ResearchOpen Access20 Jan 2000
British Journal of Cancer

Volume: 82, P: 772-776
Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study

M J Allen
M Vaughan
M E Gore
ResearchOpen Access19 Sept 2000
British Journal of Cancer

Volume: 83, P: 980-985
Cisplatin resistance is associated with reduced interferon-γ-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells

C Marth
M Widschwendter
G Daxenbichler
Research01 Nov 1997
British Journal of Cancer

Volume: 76, P: 1328-1332
Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine

D J Propper
J P Braybrooke
A L Harris
ResearchOpen Access04 May 2000
British Journal of Cancer

Volume: 82, P: 1759-1763
Hodgkins disease

C Ferme
J M Cosset
T Philip
ResearchOpen Access01 May 2001
British Journal of Cancer

Volume: 84, P: 55-60
The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate

M Arellano
M Malet-Martino
P Gires
Research01 Jan 1998
British Journal of Cancer

Volume: 77, P: 79-86
IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

J Atzpodien
H Kirchner
M Reitz
ResearchOpen Access16 Oct 2001
British Journal of Cancer

Volume: 85, P: 1130-1136
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

A Dufresne
F Bertucci
J Y Blay
ResearchOpen Access27 Jul 2010
British Journal of Cancer

Volume: 103, P: 482-485
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

P A Cassier
A Lefranc
J-Y Blay
ResearchOpen Access06 Aug 2013
British Journal of Cancer

Volume: 109, P: 909-914
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

T Eisen
R Marais
M E Gore
ResearchOpen Access12 Jul 2011
British Journal of Cancer

Volume: 105, P: 353-359
CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues

S Guichard
C Terret
P Canal
ResearchOpen Access09 Apr 1999
British Journal of Cancer

Volume: 80, P: 364-370
Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells

V Albinet
M-L Bats
N Andrieu-Abadie
Research29 Jul 2013
Oncogene

Volume: 33, P: 3364-3373
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

J-F Rossi
S Négrier
B Berns
ResearchOpen Access31 Aug 2010
British Journal of Cancer

Volume: 103, P: 1154-1162